Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering
Business Wire•30/09/2026•16:01 ET
0
Key Highlights
- ➤Lantern Pharma (LTRN) closes $4 million registered direct offering.
- ➤Offering sells 3,669,725 shares at $1.09 per share.
- ➤Warrants could provide approximately $4 million additional gross proceeds.
- ➤Warrants carry a $1.09 exercise price and expire five years after stockholder approval.
- ➤Proceeds are intended for working capital and general corporate purposes.
Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering
$4 million upfront with up to an additional $4 million of potential aggregate gross proceeds upon the exercise in full of the warrants
Get started
Create a free account to read the full story.